Innate pharma to participate in the Leerink Partners Global Healthcare Conference

On February 18, 2026 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, reported that members of its executive team will participate in a fireside chat and one-on-one investor meetings at the following conference:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leerink Partners Global Healthcare Conference 2026
• Dates: March 8–11, 2026
• Location: Miami, Florida, United States

Fireside chat:
• Date: March 9, 2026
• Time: 3:40 PM ET / 20:40 CET
• To enter the live webcast, please click here

The link to access the live webcast of the presentation will be available on the Events page of the Investors section of Innate Pharma’s website. A replay of the presentation will be available following the event.

(Press release, Innate Pharma, FEB 18, 2026, View Source [SID1234662753])